TMCnet News
Global Tryptophan Hydroxylase (TPH or Tryptophan 5-Monooxygenase) Inhibitors Pipeline Insights Report 2016 - Research and MarketsResearch and Markets has announced the addition of the "Tryptophan Hydroxylase (TPH or Tryptophan 5-Monooxygenase) Inhibitors - Pipeline Insights, 2016" report to their offering. "Tryptophan Hydroxylase (TPH or Tryptophan 5-Monooxygenase) Inhibitors - Pipeline Insights, 2016" provides in depth insights on the pipeline drugs and their development activities around the Tryptophan Hydroxylase (TPH or Tryptophan 5-Monooxygenase) Inhibitors. The report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA (News - Alert) designations details. The report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Tryptophan Hydroxylase (TPH or Tryptophan 5-Monooxygenase) Inhibitors. The report also assesses the Tryptophan Hydroxylase (TPH or Tryptophan 5-Monooxygenase) Inhibitors therapeutics by Monotherapy, Combination products, molecule type and Route of Administrtion. Scope
Key Topics Covered:
For more information visit http://www.researchandmarkets.com/research/hbt43p/tryptophan
View source version on businesswire.com: http://www.businesswire.com/news/home/20160728005853/en/ |